Abiomed Umumkan Pendapatan Q1 TA 2018 sebesar $132,5 Juta, Naik 29% dari Tahun Sebelumnya
28 juil. 2017 09h35 HE
|
Abiomed
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), penyedia utama teknologi dukungan jantung tingkat lanjut hari ini melaporkan pendapatan fiskal tahun 2018 kuartal...
Abiomed Mengumumkan Pendapatan S1 TF 2018 sebanyak $132.5 Juta, Naik 29% Berbanding Tahun Sebelumnya
28 juil. 2017 09h35 HE
|
Abiomed
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), pembekal terkemuka teknologi sokongan hati cemerlang, hari ini melaporkan pendapatan suku pertama tahun fiskal 2018...
Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year
27 juil. 2017 07h00 HE
|
Abiomed
DANVERS, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of...
Abiomed First Quarter Fiscal 2018 Earnings and Conference Call Notification
06 juil. 2017 07h00 HE
|
Abiomed
DANVERS, Mass., July 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 27, 2017, the Company will release financial results for the first quarter of fiscal...
New Study with Abiomed’s Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery
30 juin 2017 08h04 HE
|
Abiomed
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a...
Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology
09 juin 2017 08h07 HE
|
Abiomed
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) -- Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected...
Abiomed to Present at the Jefferies Healthcare Conference
30 mai 2017 08h00 HE
|
Abiomed
DANVERS, Mass., May 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017
09 mai 2017 09h33 HE
|
Abiomed
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation...
Abiomed anuncia ingresos de $124,7 millones para el cuarto trimestre del año fiscal 2017, 33% más que el año anterior, e ingresos anuales totales de $445,3 millones, 35% más que el año anterior
08 mai 2017 10h44 HE
|
Abiomed
DANVERS, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), un proveedor líder de tecnologías innovadoras para asistencia cardíaca, anunció ingresos de $124,7 millones para el...
アビオメッド(Abiomed)、2017年度第4四半期の収入は前年比33%増の1億2,470万ドル、通年の収入は前年比35%増の4億4,530ドル
08 mai 2017 10h44 HE
|
Abiomed
マサチューセッツ州ダンバース発, May 08, 2017 (GLOBE NEWSWIRE) -- 画期的な心臓サポートテクノロジーのリーディング･プロバイダー、アビオメッド (Abiomed, Inc.、NASDAQ:ABMD) は本日、2017年度第4四半期に1億2,470万ドル (約140億5,600万円) の収入を計上し、2016年度同期の9,400万ドル (約105億9,600万円)...